10 Best Australian Stocks to Buy According to Billionaires

6. Immutep Limited (NASDAQ:IMMP)

Number of Hedge Fund Holders: 2

Number of Billionaire Investors: 2

Total Value of Billionaire Holdings: $38,671

Immutep Limited (NASDAQ:IMMP) is a clinical-stage biotechnology company based in Australia that specializes in developing Lymphocyte Activation Gene immunotherapies for cancer and autoimmune diseases. On March 7, Canaccord Genuity analyst Elyse Shapiro maintained a Buy rating on the stock with a price target of A$0.95.

During the fiscal second quarter of 2025, the company announced that its TACTI-004 trial, a Phase III study in first-line non-small cell lung cancer (1L NSCLC), has received its first regulatory approval, marking the company’s transition to a Phase III biotech company. Moreover, mature data from the INSIGHT-003 trial in 1L NSCLC demonstrates a 32.9-month median overall survival and an 81.0% 24-month overall survival rate, which significantly outperforms historical controls. Immutep Limited (NASDAQ:IMMP) has a strong cash position, with A$159.26 million in aggregate cash, cash equivalents, and term deposits, providing an expected cash reach to the end of CY2026. It is one of the best Australian stocks to buy according to billionaires.